Luminex Posts 40-Percent Rise in Q1 Revenue, Swings to Profit; Shares Surge 17.5 Percent | GenomeWeb

NEW YORK, April 27 (GenomeWeb News) - Luminex today said that first-quarter revenues increased 40 percent, R&D spending inched up 1.2 percent,  and the company swung to a profit.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.